Literature DB >> 26219695

Association of immune response to endothelial cell growth factor with early disseminated and late manifestations of Lyme disease but not posttreatment Lyme disease syndrome.

Kevin S Tang1, Mark S Klempner2, Gary P Wormser3, Adriana R Marques4, Armin Alaedini1.   

Abstract

Endothelial cell growth factor has been recently proposed as a potential autoantigen in manifestations of Lyme disease that are thought to involve immune-mediated mechanisms. Our findings indicate that a humoral immune response to this protein is not associated with posttreatment Lyme disease syndrome.
© The Author 2015. Published by Oxford University Press on behalf of the Infectious Diseases Society of America. All rights reserved. For Permissions, please e-mail: journals.permissions@oup.com.

Entities:  

Keywords:  Borrelia burgdorferi; Lyme disease; antibody; endothelial cell growth factor; posttreatment Lyme disease syndrome

Mesh：

Substances：

Year:  2015        PMID： 26219695      PMCID： PMC4643484          DOI： 10.1093/cid/civ638

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN： 1058-4838            Impact factor:   9.079


  12 in total

Review 1.  A critical appraisal of "chronic Lyme disease".

Authors:  Henry M Feder; Barbara J B Johnson; Susan O'Connell; Eugene D Shapiro; Allen C Steere; Gary P Wormser; W A Agger; H Artsob; P Auwaerter; J S Dumler; J S Bakken; L K Bockenstedt; J Green; R J Dattwyler; J Munoz; R B Nadelman; I Schwartz; T Draper; E McSweegan; J J Halperin; M S Klempner; P J Krause; P Mead; M Morshed; R Porwancher; J D Radolf; R P Smith; S Sood; A Weinstein; S J Wong; L Zemel
Journal:  N Engl J Med       Date:  2007-10-04       Impact factor: 91.245

Review 2.  In the clinic. Lyme disease.

Authors:  Linden T Hu
Journal:  Ann Intern Med       Date:  2012-08-07       Impact factor: 25.391

3.  The clinical assessment, treatment, and prevention of lyme disease, human granulocytic anaplasmosis, and babesiosis: clinical practice guidelines by the Infectious Diseases Society of America.

Authors:  Gary P Wormser; Raymond J Dattwyler; Eugene D Shapiro; John J Halperin; Allen C Steere; Mark S Klempner; Peter J Krause; Johan S Bakken; Franc Strle; Gerold Stanek; Linda Bockenstedt; Durland Fish; J Stephen Dumler; Robert B Nadelman
Journal:  Clin Infect Dis       Date:  2006-10-02       Impact factor: 9.079

4.  Anti-neural antibody reactivity in patients with a history of Lyme borreliosis and persistent symptoms.

Authors:  Abhishek Chandra; Gary P Wormser; Mark S Klempner; Richard P Trevino; Mary K Crow; Norman Latov; Armin Alaedini
Journal:  Brain Behav Immun       Date:  2010-03-18       Impact factor: 7.217

Review 5.  Lyme borreliosis.

Authors:  Gerold Stanek; Gary P Wormser; Jeremy Gray; Franc Strle
Journal:  Lancet       Date:  2011-09-06       Impact factor: 79.321

6.  Elevated levels of IL-23 in a subset of patients with post-lyme disease symptoms following erythema migrans.

Authors:  Klemen Strle; Daša Stupica; Elise E Drouin; Allen C Steere; Franc Strle
Journal:  Clin Infect Dis       Date:  2013-11-11       Impact factor: 9.079

Review 7.  Chronic Lyme disease: a review.

Authors:  Adriana Marques
Journal:  Infect Dis Clin North Am       Date:  2008-06       Impact factor: 5.982

8.  Perspectives on "chronic Lyme disease".

Authors:  Phillip J Baker
Journal:  Am J Med       Date:  2008-07       Impact factor: 4.965

9.  Surveillance for Lyme disease--United States, 1992-2006.

Authors:  Rendi M Bacon; Kiersten J Kugeler; Paul S Mead
Journal:  MMWR Surveill Summ       Date:  2008-10-03

10.  Serologic markers of Lyme disease in children with autism.

Authors:  Mary Ajamian; Barry E Kosofsky; Gary P Wormser; Anjali M Rajadhyaksha; Armin Alaedini
Journal:  JAMA       Date:  2013-05-01       Impact factor: 56.272
View more
  4 in total

1.  Matrix metalloproteinase-10 is a target of T and B cell responses that correlate with synovial pathology in patients with antibiotic-refractory Lyme arthritis.

Authors:  Jameson T Crowley; Klemen Strle; Elise E Drouin; Annalisa Pianta; Sheila L Arvikar; Qi Wang; Catherine E Costello; Allen C Steere
Journal:  J Autoimmun       Date:  2016-02-26       Impact factor: 7.094

2.  Expression of C-Reactive Protein and Serum Amyloid A in Early to Late Manifestations of Lyme Disease.

Authors:  Melanie Uhde; Mary Ajamian; Xueting Li; Gary P Wormser; Adriana Marques; Armin Alaedini
Journal:  Clin Infect Dis       Date:  2016-09-01       Impact factor: 9.079

Review 3.  Persistent Symptoms After Treatment of Lyme Disease.

Authors:  Adriana Marques
Journal:  Infect Dis Clin North Am       Date:  2022-09       Impact factor: 5.905

Review 4.  Lyme arthritis: linking infection, inflammation and autoimmunity.

Authors:  Robert B Lochhead; Klemen Strle; Sheila L Arvikar; Janis J Weis; Allen C Steere
Journal:  Nat Rev Rheumatol       Date:  2021-07-05       Impact factor: 32.286
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.